Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing

Software for Dosage Individualization of Voriconazole for Immunocompromised Patients

(2013) William W. Hope et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Steady-state pharmacokinetics and metabolism of voriconazole in patients

(2013) M. J. P. Geist et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Voriconazole Serum Concentrations in Obese and Overweight Immunocompromised Patients: A Retrospective Review

(2013) Samantha Davies-Vorbrodt et al.   PHARMACOTHERAPY

Performance of Methods for Handling Missing Categorical Covariate Data in Population Pharmacokinetic Analyses

(2012) Ron J. Keizer et al.   AAPS Journal

Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring

(2012) Michael J. Dolton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Integrated Population Pharmacokinetic Analysis of Voriconazole in Children, Adolescents, and Adults

(2012) Lena E. Friberg et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial

(2012) Wan Beom Park et al.   CLINICAL INFECTIOUS DISEASES

Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics–Based Analysis of Adult Patients With Invasive Fungal Infections

(2012) Andres Pascual et al.   CLINICAL INFECTIOUS DISEASES

Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models

(2011) Martin Bergstrand et al.   AAPS Journal

Population Pharmacokinetics of Voriconazole in Adults

(2011) William W. Hope   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Steady-State Plasma Pharmacokinetics of Oral Voriconazole in Obese Adults

(2011) Manjunath P. Pai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients

(2011) Peter F. Troke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetic Evaluation with External Validation and Bayesian Estimator of Voriconazole in Liver Transplant Recipients

(2011) Kelong Han et al.   CLINICAL PHARMACOKINETICS

Determining the Time Course of CYP3A Inhibition by Potent Reversible and Irreversible CYP3A Inhibitors Using A Limited Sampling Strategy

(2011) S Katzenmaier et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy Volunteers

(2011) SeungHwan Lee et al.   JOURNAL OF CLINICAL PHARMACOLOGY

PharmGKB summary

(2011) Stuart A. Scott et al.   Pharmacogenetics and Genomics

Modulators of Very Low Voriconazole Concentrations in Routine Therapeutic Drug Monitoring

(2011) Arwa Hassan et al.   THERAPEUTIC DRUG MONITORING

Clinical importance of the CYP2C19*17 variant allele for voriconazole

(2010) Michael J. Dolton et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype

(2009) Ina Scholz et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Voriconazole concentrations and outcome of invasive fungal infections

(2009) S. Miyakis et al.   CLINICAL MICROBIOLOGY AND INFECTION

Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders

(2009) Koki Ueda et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Complexity of Interactions Between Voriconazole and Antiretroviral Agents

(2008) Erin M Yakiwchuk et al.   ANNALS OF PHARMACOTHERAPY

CYP2C19Genotype Is a Major Factor Contributing to the Highly Variable Pharmacokinetics of Voriconazole

(2008) Johanna Weiss et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

(2007) A. Pascual et al.   CLINICAL INFECTIOUS DISEASES